OPMN Expert Panel – Current Members

The network’s expert panel is drawn from a broad stakeholder community, including individuals involved in strategic and operational aspects of personalized medicine such as senior representatives of hospitals, universities, research institutes, industry, non-governmental organizations, charities, and provincial ministries. The panel members come from diverse backgrounds and include experts in research, policy, law, administration, economics, commercialization and patient care. Membership is flexible and changes based on the needs of the network in its analysis of current issues, recommendations of the steering committee and interest from stakeholders.

  • Mark Poznansky (Chair)– President and CEO, Ontario Genomics
  • Kathy Deuchars (Director)– Senior Manager, Business Development and Research, Ontario Genomics
  • Allison Barr– Director, Office of the Chief Science Officer, Economic Development and Growth
  • June Carroll– Sydney G. Frankfort Chair in Family Medicine; Associate Professor, Department of Family & Community Medicine, Mount Sinai Hospital, University of Toronto
  • Ron Carter– Director, Molecular Genetics Laboratory, LifeLabs Medical Laboratory Services
  • Jill Davies– Director, Genetics Program, Medcan Clinic
  • Brenda Gallie– Head of the Retinoblastoma Program, The Hospital for Sick Children Department of Ophthalmology and Vision Sciences
  • Jack Gauldie– Distinguished University Professor, Department of Pathology and Molecular Medicine; Director, Institute for Molecular Medicine and Health, McMaster University
  • Suzanne Kamel-Reid– Head, Clinical Laboratory Genetics and Director, Molecular Diagnostics, University Health Network
  • Bartha Knoppers– Director, the Centre of Genomics and Policy, Faculty of Medicine, Department of Human Genetics, McGill University
  • Mark Lievonen– President, Sanofi Pasteur Ltd.
  • Fiona Miller– Associate Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
  • Amit Oza– Senior Staff Physician, Professor of Medicine, Princess Margaret Hospital, University of Toronto
  • Margaret Piper– Senior Investigator, Kaiser Permanente Research Affiliates Evidence-Based Practice Center
  • Caroline Popper– Founder and President, Popper and Company LLC
  • Beni Rovinski– Managing Director, Lumira Capital
  • Stephen Scherer– Director, The Centre for Applied Genomics, The Hospital for Sick Children; Director, McLaughlin Centre for Molecular Medicine, University of Toronto
  • Katherine Siminovitch– Senior Investigator, Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Professor of Medicine, University of Toronto
  • Vasanthi Srinivasan– Executive Director, Ontario Strategy for Patient-Oriented Research SUPPORT Unit
  • Jeffrey Weitz– Professor of Medicine and Biochemistry, McMaster University; Director, Juravinski Hospital and Cancer Center